Zobrazeno 1 - 10
of 50
pro vyhledávání: '"J. C. A. Hoorntje"'
Autor:
A. Ghani, J. C. A. Hoorntje, J.H.E. Dambrink, J. P. Ottervanger, A. W. J. van ’t Hof, A. T. M. Gosselink
Publikováno v:
Netherlands Heart Journal. 20:347-353
There are conflicting data regarding optimal treatment of non-culprit lesions detected during primary percutaneous coronary intervention (PCI) in patients with ST-elevation myocardial infarction (STEMI) and multi-vessel disease (MVD). We aimed to inv
Autor:
R. S. Hermanides, A. W. J. van ’t Hof, A. T. M. Gosselink, Jan Paul Ottervanger, J. C. A. Hoorntje, Freek J. Zijlstra, Harry Suryapranata, M.J. de Boer, J.H.E. Dambrink
Publikováno v:
Thrombosis and Haemostasis, 106(4), 636-640. Georg Thieme Verlag
Thrombosis and Haemostasis, 106, 636-40
Thrombosis and Haemostasis, 106, 4, pp. 636-40
Thrombosis and Haemostasis, 106, 636-40
Thrombosis and Haemostasis, 106, 4, pp. 636-40
SummaryThis is a prospective, observational study performed in all consecutive ST-elevation myocardial infarction (STEMI) patients who had activated clotting time (ACT) measurement on arrival in the cathlab before coronary angiography. We studied the
Autor:
M de Boer, H. Suryapranata, D. A. A. M. Schellings, J. C. A. Hoorntje, A. W. J. van ’t Hof, J.H.E. Dambrink
Publikováno v:
Netherlands Heart Journal, 18, 307-13
Netherlands Heart Journal, 18, 6, pp. 307-13
Netherlands Heart Journal, 18, 6, pp. 307-13
Item does not contain fulltext Background. In patients with unstable angina or non-ST-elevation acute coronary syndrome (NSTE-ACS) who are eligible for PCI, routine stenting is the recommended treatment strategy, based on the opinion of experts. Prov
Autor:
Dambrink Jh, de Boer Mj, van 't Hof Aw, Debrauwere Jp, Harry Suryapranata, A. T. M. Gosselink, Jan Paul Ottervanger, J. C. A. Hoorntje
Publikováno v:
Eurointervention, 5, 968-75
Eurointervention, 5, 8, pp. 968-75
Eurointervention, 5, 8, pp. 968-75
Item does not contain fulltext AIMS: Evidence regarding the optimal treatment of non-culprit lesions detected during primary PCI is lacking. Our aim was to investigate whether early invasive treatment improves left ventricular ejection fraction (EF)
Autor:
A. T. M. Gosselink, Jan Paul Ottervanger, J. C. A. Hoorntje, A. W. J. van ’t Hof, Dambrink Jh, Harry Suryapranata, M.J. de Boer, R. S. Hermanides
Publikováno v:
Eurointervention, 6, 106-11
Eurointervention, 6, 1, pp. 106-11
Eurointervention, 6, 1, pp. 106-11
Item does not contain fulltext AIMS: To investigate incidence, predictors and prognosis of bleeding in ST elevation myocardial infarction (STEMI) patients who underwent primary percutaneous coronary intervention (PCI). METHODS AND RESULTS: A large sc
Autor:
A. T. M. Gosselink, Christian W. Hamm, M.J. de Boer, Thorsten Dill, J. M. ten Berg, G. K. van Houwelingen, A. W. J. Van âT Hof, Petra C. Koopmans, J. C. A. Hoorntje, J. W. Van Werkum, A. A. C. M. Heestermans
Publikováno v:
Journal of Thrombosis and Haemostasis. 7:1612-1618
Summary. Background: No randomized comparisons are yet available evaluating the effect of pre-hospital high dose tirofiban on the incidence of early stent thrombosis after primary percutaneous coronary intervention (PCI). Objectives: The aim of this
Autor:
H. Suryapranata, J. P. Ottervanger, A. T. M. Gosselink, J. C. A. Hoorntje, Dambrink Jh, de Boer Mj, Mark B. Nienhuis, van 't Hof Aw
Publikováno v:
Coronary Artery Disease. 20:9-14
OBJECTIVE: Although infarct location may predict prognosis after primary percutaneous coronary intervention (PCI) for ST elevation myocardial infarction, previous studies were powered insufficiently to be able to show whether this association is inde
Autor:
J R, Timmer, I C C, van der Horst, J P S, Henriques, K, Thomas, H J G, Bilo, J C A, Hoorntje, M J, de Boer, H, Suryapranata, F, Zijlstra
Publikováno v:
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation. 11(10)
We sought to compare long-term survival after ST-segment elevation myocardial infarction (STEMI) in patients with and without diabetes mellitus (DM) treated with primary percutaneous coronary intervention (PCI) or thrombolytic therapy.DM is an advers
Autor:
N, Ernst, F, Zijlstra, M J, de Boer, J H E, Dambrink, A T M, Gosselink, J P S, Henriques, A W J, van 't Hof, J C A, Hoorntje, J C C, van der Horst, H, Suryapranata
Publikováno v:
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation. 11(1)
To study the impact of patency of the infarct-related artery on the coronary angiogram, both before and after primary angioplasty for acute myocardial infarction, on 30-day mortality.Data of 1702 consecutive patients treated with primary angioplasty
Autor:
J P S, Henriques, P J, Gheeraert, F, Zijlstra, A W J, van 't Hof, M-J, de Boer, J-H E, Dambrink, A T M, Gosselink, J C A, Hoorntje, J P, Ottervanger, H, Suryapranata
Publikováno v:
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation. 12(1)
Early VF accounts for the majority of deaths during the acute phase of acute MI. In patients treated with fibrinolytics, in-hospital VF occurs most frequently with inferior MI. Contrariwise, out-of-hospital VF seems to be associated with anterior wal